Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Asset Utilization Ratio (2018 - 2025)

Catalyst Pharmaceuticals' Asset Utilization Ratio history spans 12 years, with the latest figure at 0.55 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 9.79% year-over-year to 0.55; the TTM value through Dec 2025 reached 0.55, down 9.79%, while the annual FY2025 figure was 0.6, 19.05% down from the prior year.
  • Asset Utilization Ratio reached 0.55 in Q4 2025 per CPRX's latest filing, down from 0.57 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.9 in Q4 2023 to a low of 0.55 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.65, with a median of 0.62 recorded in 2021.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 40.33% in 2021, then soared 49.16% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.61 in 2021, then decreased by 1.06% to 0.6 in 2022, then skyrocketed by 49.16% to 0.9 in 2023, then plummeted by 32.81% to 0.61 in 2024, then dropped by 9.79% to 0.55 in 2025.
  • Per Business Quant, the three most recent readings for CPRX's Asset Utilization Ratio are 0.55 (Q4 2025), 0.57 (Q3 2025), and 0.59 (Q2 2025).